Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)

This study has been terminated.
(Lack of funding)
Sponsor:
Collaborator:
Sanofi
Information provided by:
Capital District Health Authority, Canada
ClinicalTrials.gov Identifier:
NCT00688948
First received: May 30, 2008
Last updated: June 23, 2011
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2009
  Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)